SynthesisVeterinary research2025
Insights into the multifunctionality of viral glycoproteins F and HN in the lifecycle and pathogenesis of Newcastle disease virus: a systematic review.
Synthesis in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Dual-expression-site fowl adenovirus 4 (FAdV-4) with high viral titer: a promising viral vector for multivalent poultry vaccines.Veterinary research · 2026Article
- Newcastle Disease Virus Fusion and Haemagglutinin-Neuraminidase Gene Divergence: Implications for Vaccines.Veterinary sciences · 2026Article
- A DNA Prime-Inactivated Boost Regimen Enhances Immunogenicity Against Pigeon Newcastle Disease: A Comparative Study and Analysis of Synergistic Effects.Veterinary sciences · 2026Article
- Review on bioactive compounds of medicinal plants with antiviral properties against Newcastle disease virus (NDV).Archives of virology · 2026Review
- Molecular Characterization of Publicly Available NDV F Gene Sequences From Bangladesh (2010-2024).Veterinary medicine international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Newcastle disease virus (NDV) is a representative paramyxovirus that usually causes severe infections and substantial economic losses to the global poultry industry. Over the years, NDV has attracted widespread attention as a promising oncolytic virotherapy agent and vector vaccine against many pathogens and an important prototype for elucidating the replication and pathogenesis of other paramyxoviruses. The F and HN glycoproteins are two kinds of glycosylated transmembrane proteins located on the virion envelope that play multiple roles in the virulence, infection, replication, and pathogenicity of NDV. In view of the ability to induce neutralizing and protective antibodies and the similarity in the structural features of the F and HN glycoproteins of NDV and other paramyxoviruses, investigating their structures and functions is beneficial for understanding the viral lifecycle and pathogenesis and developing more effective broad-spectrum antibodies or antiviral drugs against viral infection. This systematic review aims to summarize the structural features and membrane fusion mechanism of the F and HN glycoproteins and their relationships with viral virulence, pathogenic phenotype and thermostability, coupled with the crucial roles of F/HN-host protein/compound interactions in the infection, replication, and pathogenicity of NDV. Additionally, this review also highlights the importance of technologies such as protein‒protein interactome analysis, single-particle cryo-electron microscopy, genome-wide CRISPR/Cas9 library screening, and computational structural biology for providing novel viewpoints on the lifecycle and pathogenesis of NDV and related paramyxoviruses and valuable reference information for the future development of efficient treatment strategies targeting viral glycoproteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.